世界の心臓再同期療法（CRT）装置市場予測（～2028年）：心臓再同期療法用ペースメーカー、心臓再同期療法用除細動器

• 英文タイトル：Global Cardiac Resynchronisation Therapy (CRT) Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7689 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

心臓再同期療法（CRT）装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の心臓再同期療法（CRT）装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 心臓再同期療法（CRT）装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・心臓再同期療法用ペースメーカー、心臓再同期療法用除細動器 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の心臓再同期療法（CRT）装置市場の主要な市場プレーヤーは以下のとおりです。 ・Medtronic、Boston Scientific、Biotronik、Livanova、Abbott、Cook Medical、Sorin Group 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、心臓再同期療法（CRT）装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な心臓再同期療法（CRT）装置メーカーの企業概要、2019年～2022年までの心臓再同期療法（CRT）装置の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な心臓再同期療法（CRT）装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別心臓再同期療法（CRT）装置の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの心臓再同期療法（CRT）装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での心臓再同期療法（CRT）装置市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および心臓再同期療法（CRT）装置の産業チェーンを掲載しています。 ・第13、14、15章では、心臓再同期療法（CRT）装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Medtronic、Boston Scientific、Biotronik、Livanova、Abbott、Cook Medical、Sorin Group ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：心臓再同期療法用ペースメーカー、心臓再同期療法用除細動器 ・用途別分析2017年-2028年：病院、クリニック、その他 ・心臓再同期療法（CRT）装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・心臓再同期療法（CRT）装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・心臓再同期療法（CRT）装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・心臓再同期療法（CRT）装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・心臓再同期療法（CRT）装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Cardiac Resynchronisation Therapy (CRT) Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cardiac Resynchronisation Therapy (CRT) Device market size is estimated to be worth US$ 6289.7 million in 2021 and is forecast to a readjusted size of USD 9116.3 million by 2028 with a CAGR of 5.4% during review period. Hospital accounting for % of the Cardiac Resynchronisation Therapy (CRT) Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cardiac Resynchronization Therapy Pacemakers segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cardiac Resynchronisation Therapy (CRT) Device include Medtronic, Boston Scientific, Biotronik, Livanova, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cardiac Resynchronisation Therapy (CRT) Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cardiac Resynchronization Therapy Pacemakers
Cardiac Resynchronization Therapy Defibrillators
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Cardiac Resynchronisation Therapy (CRT) Device market are listed below:
Medtronic
Boston Scientific
Biotronik
Livanova
Abbott
Cook Medical
Sorin Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiac Resynchronisation Therapy (CRT) Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cardiac Resynchronisation Therapy (CRT) Device, with price, sales, revenue and global market share of Cardiac Resynchronisation Therapy (CRT) Device from 2019 to 2022.
Chapter 3, the Cardiac Resynchronisation Therapy (CRT) Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiac Resynchronisation Therapy (CRT) Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cardiac Resynchronisation Therapy (CRT) Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cardiac Resynchronisation Therapy (CRT) Device.
Chapter 13, 14, and 15, to describe Cardiac Resynchronisation Therapy (CRT) Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Cardiac Resynchronisation Therapy (CRT) Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cardiac Resynchronisation Therapy (CRT) Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cardiac Resynchronization Therapy Pacemakers
1.2.3 Cardiac Resynchronization Therapy Defibrillators
1.3 Market Analysis by Application
1.3.1 Overview: Global Cardiac Resynchronisation Therapy (CRT) Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Cardiac Resynchronisation Therapy (CRT) Device Market Size & Forecast
1.4.1 Global Cardiac Resynchronisation Therapy (CRT) Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume (2017-2028)
1.4.3 Global Cardiac Resynchronisation Therapy (CRT) Device Price (2017-2028)
1.5 Global Cardiac Resynchronisation Therapy (CRT) Device Production Capacity Analysis
1.5.1 Global Cardiac Resynchronisation Therapy (CRT) Device Total Production Capacity (2017-2028)
1.5.2 Global Cardiac Resynchronisation Therapy (CRT) Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cardiac Resynchronisation Therapy (CRT) Device Market Drivers
1.6.2 Cardiac Resynchronisation Therapy (CRT) Device Market Restraints
1.6.3 Cardiac Resynchronisation Therapy (CRT) Device Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.1.4 Medtronic Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.2.4 Boston Scientific Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biotronik
2.3.1 Biotronik Details
2.3.2 Biotronik Major Business
2.3.3 Biotronik Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.3.4 Biotronik Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Livanova
2.4.1 Livanova Details
2.4.2 Livanova Major Business
2.4.3 Livanova Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.4.4 Livanova Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.5.4 Abbott Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cook Medical
2.6.1 Cook Medical Details
2.6.2 Cook Medical Major Business
2.6.3 Cook Medical Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.6.4 Cook Medical Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sorin Group
2.7.1 Sorin Group Details
2.7.2 Sorin Group Major Business
2.7.3 Sorin Group Cardiac Resynchronisation Therapy (CRT) Device Product and Services
2.7.4 Sorin Group Cardiac Resynchronisation Therapy (CRT) Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cardiac Resynchronisation Therapy (CRT) Device Breakdown Data by Manufacturer
3.1 Global Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cardiac Resynchronisation Therapy (CRT) Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cardiac Resynchronisation Therapy (CRT) Device
3.4 Market Concentration Rate
3.4.1 Top 3 Cardiac Resynchronisation Therapy (CRT) Device Manufacturer Market Share in 2021
3.4.2 Top 6 Cardiac Resynchronisation Therapy (CRT) Device Manufacturer Market Share in 2021
3.5 Global Cardiac Resynchronisation Therapy (CRT) Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cardiac Resynchronisation Therapy (CRT) Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cardiac Resynchronisation Therapy (CRT) Device Market Size by Region
4.1.1 Global Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Region (2017-2028)
4.1.2 Global Cardiac Resynchronisation Therapy (CRT) Device Revenue by Region (2017-2028)
4.2 North America Cardiac Resynchronisation Therapy (CRT) Device Revenue (2017-2028)
4.3 Europe Cardiac Resynchronisation Therapy (CRT) Device Revenue (2017-2028)
4.4 Asia-Pacific Cardiac Resynchronisation Therapy (CRT) Device Revenue (2017-2028)
4.5 South America Cardiac Resynchronisation Therapy (CRT) Device Revenue (2017-2028)
4.6 Middle East and Africa Cardiac Resynchronisation Therapy (CRT) Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Type (2017-2028)
5.2 Global Cardiac Resynchronisation Therapy (CRT) Device Revenue by Type (2017-2028)
5.3 Global Cardiac Resynchronisation Therapy (CRT) Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Application (2017-2028)
6.2 Global Cardiac Resynchronisation Therapy (CRT) Device Revenue by Application (2017-2028)
6.3 Global Cardiac Resynchronisation Therapy (CRT) Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cardiac Resynchronisation Therapy (CRT) Device Sales by Type (2017-2028)
7.2 North America Cardiac Resynchronisation Therapy (CRT) Device Sales by Application (2017-2028)
7.3 North America Cardiac Resynchronisation Therapy (CRT) Device Market Size by Country
7.3.1 North America Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Country (2017-2028)
7.3.2 North America Cardiac Resynchronisation Therapy (CRT) Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cardiac Resynchronisation Therapy (CRT) Device Sales by Type (2017-2028)
8.2 Europe Cardiac Resynchronisation Therapy (CRT) Device Sales by Application (2017-2028)
8.3 Europe Cardiac Resynchronisation Therapy (CRT) Device Market Size by Country
8.3.1 Europe Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Cardiac Resynchronisation Therapy (CRT) Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cardiac Resynchronisation Therapy (CRT) Device Sales by Type (2017-2028)
9.2 Asia-Pacific Cardiac Resynchronisation Therapy (CRT) Device Sales by Application (2017-2028)
9.3 Asia-Pacific Cardiac Resynchronisation Therapy (CRT) Device Market Size by Region
9.3.1 Asia-Pacific Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cardiac Resynchronisation Therapy (CRT) Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cardiac Resynchronisation Therapy (CRT) Device Sales by Type (2017-2028)
10.2 South America Cardiac Resynchronisation Therapy (CRT) Device Sales by Application (2017-2028)
10.3 South America Cardiac Resynchronisation Therapy (CRT) Device Market Size by Country
10.3.1 South America Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Country (2017-2028)
10.3.2 South America Cardiac Resynchronisation Therapy (CRT) Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cardiac Resynchronisation Therapy (CRT) Device Sales by Type (2017-2028)
11.2 Middle East & Africa Cardiac Resynchronisation Therapy (CRT) Device Sales by Application (2017-2028)
11.3 Middle East & Africa Cardiac Resynchronisation Therapy (CRT) Device Market Size by Country
11.3.1 Middle East & Africa Cardiac Resynchronisation Therapy (CRT) Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cardiac Resynchronisation Therapy (CRT) Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cardiac Resynchronisation Therapy (CRT) Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cardiac Resynchronisation Therapy (CRT) Device
12.3 Cardiac Resynchronisation Therapy (CRT) Device Production Process
12.4 Cardiac Resynchronisation Therapy (CRT) Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cardiac Resynchronisation Therapy (CRT) Device Typical Distributors
13.3 Cardiac Resynchronisation Therapy (CRT) Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---